CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Liberal Red Blood Cell Transfusion Strategy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02483351
NCT02483351Phase 3Completed
CompareCT.gov

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial

Ottawa Hospital Research Institute·interventional·Posted Jun 26, 2015·Updated Apr 4, 2018

In Brief

A Phase 3 clinical trial evaluating Liberal Red Blood Cell Transfusion Strategy and Restrictive Red Blood Cell Transfusion Strategy for Subarachnoid Hemorrhage. Completed, enrolled 60 participants across 3 sites.

Detailed Summary

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubarachnoid Hemorrhage
CountriesCanada
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 26, 2015
Enrollment StartOct 1, 2015
Primary CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.0 years ago

Interventions

Liberal Red Blood Cell Transfusion Strategyother

RBC Transfusion strategy with hemoglobin trigger of 100g/L

Restrictive Red Blood Cell Transfusion Strategyother

Optional RBC Transfusion with hemoglobin trigger of \<=80g/L